Q3 2023 Holdings
Filed 2023-11-13 | 23 holdings | $301.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Quidelortho Corp(QDEL) | COM | 219798105 | $48.1M | 658,794 | 16.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $47.3M | 5,179,004 | 15.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $46.1M | 2,515,868 | 15.3% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $32.6M | 9,104,275 | 10.8% |
| Galapagos NV(GLPG) | SPONS ADR | 36315X101 | $27.7M | 802,544 | 9.2% |
| Alimera Sciences Inc | COM NEW | 016259202 | $12.3M | 3,983,686 | 4.1% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $11.7M | 3,761,640 | 3.9% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $11.0M | 5,915,372 | 3.7% |
| Gamida Cell LTD | SHS | M47364100 | $8.2M | 7,965,865 | 2.7% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $7.3M | 4,626,624 | 2.4% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $6.5M | 2,852,599 | 2.2% |
| Xoma Corp(XOMA) | COM NEW | 98419J206 | $6.2M | 436,602 | 2.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $5.7M | 5,273,685 | 1.9% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $5.2M | 1,720,000 | 1.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $4.1M | 3,072,476 | 1.3% |
| Tela BIO Inc(TELA) | COM | 872381108 | $3.9M | 491,919 | 1.3% |
| Exagen Inc(XGN) | COM | 30068X103 | $2.9M | 1,203,491 | 1.0% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $2.8M | 1,975,308 | 0.9% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $2.8M | 3,339,405 | 0.9% |
| Delcath Systems Inc(DCTH) | COM NEW | 24661P807 | $2.8M | 686,240 | 0.9% |
| Assertio Holdings Inc | COM NEW | 04546C205 | $2.4M | 951,197 | 0.8% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $2.1M | 477,903 | 0.7% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $1.3M | 472,369 | 0.4% |